SYNIMMUNE GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2010-07-07
- Employees
- -
- Market Cap
- -
- Website
- http://www.synimmune.de
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)FLYSYN in MRD Positive AML
Phase 1
Completed
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2016-06-02
- Last Posted Date
- 2023-12-28
- Lead Sponsor
- Synimmune GmbH
- Target Recruit Count
- 31
- Registration Number
- NCT02789254
- Locations
- 🇩🇪
University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany
🇩🇪University Hospital Ulm, Ulm, Baden-Wuerttemberg, Germany
🇩🇪Hannover Medical School, Hannover, Niedersachsen, Germany
News
No news found